FdaApplication
ANDA 215572
Identifiers
- fda_app_no: ANDA215572
Properties
| Property | Value |
|---|---|
| applicant_name | AMNEAL PHARMACEUTICALS LLC |
| application_type | ANDA |
| approval_date | 2023-09-05 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| SPIRONOLACTONE | SPIRONOLACTONE | 25MG/5ML | SUSPENSION;ORAL |
1 product